Advertisement
YOU ARE HERE: LAT HomeCollections

The Nation

December 27, 1985

A synthetic hormone appears to help delay or prevent a recurrence of breast cancer in some women who have had surgery for the disease, and without side effects associated with chemotherapy, a new study said. But for breast cancer sufferers who have not reached menopause, treatment by the new hormone, tamoxifen, does not work, and chemotherapy should be considered standard care even though it can cause side effects, said the study, which was published in the Journal of the American Medical Assn.

Advertisement
Los Angeles Times Articles
|
|
|